Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia

NCT: NCT05591040 · RECRUITING

NCT IDNCT05591040
StatusRECRUITING
Start Date2022-10-30
Completion2027-12-03

Brief Summary

The aim of the study is to evaluate whether the effect of biofeedback treatment is more effective than a control treatment in the recovery of dysphagia. This study will be a multicentric randomized, single-blind controlled study. The investigators intend to recruit 100 patients who have suffered a stroke and have dysphagia. Fifty patients will undergo training with bio-feedback (experimental group) and the other fifty patients will undergo standard training, using only verbal feedback rather than visual feedback (control group). Our hypothesis, based on the results obtained in some previous studies, is that in the control group the efficacy of the treatment will be lower in the absence of immediate visual feedback of strength, timing, coordination and efficacy of the swallowing act.

Frequently Asked Questions

What is Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia?

Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia is a clinical trial registered under NCT05591040. Current status: RECRUITING.

What is the status of NCT05591040?

The current status of NCT05591040 (Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia) is: RECRUITING.

When did Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia start?

Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia started on 2022-10-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.